To skeptics, looking for cancer drugs by screening cell lines is the equivalent of searching for your lost wallet under a street lamp. The types of cells that can be cultured, the argument goes, are different in critical ways from those that can't, and any knowledge gleaned from them is likely to lead drug developers down a primrose path that ends in clinical failure.